About Ulthera, Inc.

Ulthera's mission is to work with physicians to provide therapeutic
ultrasound to improve the appearance and health of patients worldwide.

Ulthera, Inc. was founded in 2004 to leverage seven years of prior scientific research in therapeutic ultrasound for aesthetic and medical applications. In 2009, the Ulthera® System received FDA approval in the United States and is the first and only energy-based device to receive FDA clearance for a non-invasive aesthetic lift indication.  The first application for Ultherapy® – the procedure enabled by the System – is a non-invasive treatment of the face to achieve a brow lift.  Learn more about the technology.

Ulthera’s robust scientific foundation and relentless pursuit of superior clinical outcomes have resulted in the rapid global uptake of the Ulthera platform. As Ulthera continues to develop and provide more applications for its platform, the company also remains committed to bringing value to physicians and their patients.

The company is not only defined by its proprietary technology, but also its people. Ulthera’s team consists of experts in their respective fields who are aligned by the strength of the company’s mission and its leadership.  Learn more about the Leadership Team.

Ulthera, Inc. is based in Mesa, Arizona and is backed by top-tier venture capital firms, New Enterprise Associates and Apposite Capital.